Free Trial
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

Ampio Pharmaceuticals logo
$0.0030 0.00 (0.00%)
As of 05/28/2025

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Key Stats

Today's Range
$0.0030
$0.0030
50-Day Range
N/A
52-Week Range
$0.00
$0.45
Volume
1 shs
Average Volume
435 shs
Market Capitalization
$3,405.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Stock News Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
Ampio Pharmaceuticals, Inc. (AMPE)
See More Headlines

AMPE Stock Analysis - Frequently Asked Questions

Ampio Pharmaceuticals' stock was trading at $0.0026 on January 1st, 2025. Since then, AMPE shares have increased by 15.4% and is now trading at $0.0030.
View the best growth stocks for 2025 here
.

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) posted its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.40) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.40).

Shares of Ampio Pharmaceuticals reverse split on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ampio Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Trevena (TRVN), GE Aerospace (GE) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/10/2021
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:AMPE
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.00

Miscellaneous

Free Float
1,098,000
Market Cap
$3,405.00
Optionable
No Data
Beta
3.90
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:AMPE) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners